Swedish Orphan Biovitrum 552953CD1 Bond

B6E Stock  EUR 26.86  0.00  0.00%   
Swedish Orphan Biovitrum has over 8.78 Billion in debt which may indicate that it relies heavily on debt financing. . Swedish Orphan's financial risk is the risk to Swedish Orphan stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Swedish Orphan's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Swedish Orphan's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Swedish Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Swedish Orphan's stakeholders.
For most companies, including Swedish Orphan, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Swedish Orphan Biovitrum, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Swedish Orphan's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
  
Check out the analysis of Swedish Orphan Fundamentals Over Time.
View Bond Profile
Given the importance of Swedish Orphan's capital structure, the first step in the capital decision process is for the management of Swedish Orphan to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Swedish Orphan Biovitrum to issue bonds at a reasonable cost.
Popular NameSwedish Orphan MGM Resorts International
Equity ISIN CodeSE0000872095
Bond Issue ISIN CodeUS552953CD18
S&P Rating
Others
Maturity Date1st of September 2026
Issuance Date19th of August 2016
Coupon4.625 %
View All Swedish Orphan Outstanding Bonds

Swedish Orphan Biovitrum Outstanding Bond Obligations

Understaning Swedish Orphan Use of Financial Leverage

Swedish Orphan's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Swedish Orphan's total debt position, including all outstanding debt obligations, and compares it with Swedish Orphan's equity. Financial leverage can amplify the potential profits to Swedish Orphan's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Swedish Orphan is unable to cover its debt costs.
Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, immunology, and genetic and metabolic diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. SWEDISH ORPHAN is traded on Frankfurt Stock Exchange in Germany.
Please read more on our technical analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Swedish Stock

Swedish Orphan financial ratios help investors to determine whether Swedish Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Swedish with respect to the benefits of owning Swedish Orphan security.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.